McCollum Christoferson Group LLC reduced its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 5.4% during the fourth quarter, Holdings Channel reports. The firm owned 5,945 shares of the company’s stock after selling 340 shares during the quarter. McCollum Christoferson Group LLC’s holdings in Clorox were worth $966,000 at the end of the most recent quarter.
Several other institutional investors have also added to or reduced their stakes in CLX. Brooklyn Investment Group increased its position in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares during the period. Continuum Advisory LLC boosted its position in Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after acquiring an additional 138 shares in the last quarter. Millstone Evans Group LLC purchased a new position in shares of Clorox during the 4th quarter worth approximately $31,000. Asset Planning Inc bought a new position in shares of Clorox in the 4th quarter worth approximately $32,000. Finally, Halbert Hargrove Global Advisors LLC purchased a new position in shares of Clorox in the 4th quarter valued at approximately $36,000. 78.53% of the stock is currently owned by institutional investors.
Clorox Price Performance
NYSE CLX opened at $144.88 on Monday. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The stock has a 50-day moving average of $152.84 and a 200 day moving average of $159.74. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The company has a market capitalization of $17.85 billion, a price-to-earnings ratio of 39.58, a PEG ratio of 2.62 and a beta of 0.45.
Clorox Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.37%. Clorox’s payout ratio is 133.33%.
Wall Street Analyst Weigh In
CLX has been the subject of a number of research reports. Evercore ISI increased their price objective on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Barclays increased their price target on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research note on Wednesday, February 5th. Wells Fargo & Company boosted their price objective on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Finally, DA Davidson dropped their price target on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. Three equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $159.62.
View Our Latest Analysis on Clorox
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
- Five stocks we like better than Clorox
- 3 Warren Buffett Stocks to Buy Now
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- 3 ETFs to Ride the VIX Surge During Market Volatility
- The Most Important Warren Buffett Stock for Investors: His Own
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.